These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 30725424

  • 1. Recombinant Methioninase as a DNA Demethylation Agent.
    Hoffman RM, Machover D.
    Methods Mol Biol; 2019; 1866():279-284. PubMed ID: 30725424
    [Abstract] [Full Text] [Related]

  • 2. Treatment of cancer cells with methioninase produces DNA hypomethylation and increases DNA synthesis.
    Machover D, Zittoun J, Saffroy R, Broët P, Giraudier S, Magnaldo T, Goldschmidt E, Debuire B, Orrico M, Tan Y, Mishal Z, Chevallier O, Tonetti C, Jouault H, Ulusakarya A, Tanguy ML, Metzger G, Hoffman RM.
    Cancer Res; 2002 Aug 15; 62(16):4685-9. PubMed ID: 12183426
    [Abstract] [Full Text] [Related]

  • 3. Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient-Derived Orthotopic Xenograft Model.
    Sugisawa N, Yamamoto J, Han Q, Tan Y, Tashiro Y, Nishino H, Inubushi S, Hamada K, Kawaguchi K, Unno M, Bouvet M, Hoffman RM.
    Pancreas; 2021 Jan 01; 50(1):93-98. PubMed ID: 33370029
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid.
    Machover D, Zittoun J, Broët P, Metzger G, Orrico M, Goldschmidt E, Schilf A, Tonetti C, Tan Y, Delmas-Marsalet B, Luccioni C, Falissard B, Hoffman RM.
    Biochem Pharmacol; 2001 Apr 01; 61(7):867-76. PubMed ID: 11274973
    [Abstract] [Full Text] [Related]

  • 5. Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells In Vitro.
    Tan Y, Xu M, Hoffman RM.
    Anticancer Res; 2010 Apr 01; 30(4):1041-6. PubMed ID: 20530407
    [Abstract] [Full Text] [Related]

  • 6. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Murakami T, Li S, Han Q, Tan Y, Kiyuna T, Igarashi K, Kawaguchi K, Hwang HK, Miyake K, Singh AS, Nelson SD, Dry SM, Li Y, Hiroshima Y, Lwin TM, DeLong JC, Chishima T, Tanaka K, Bouvet M, Endo I, Eilber FC, Hoffman RM.
    Oncotarget; 2017 May 30; 8(22):35630-35638. PubMed ID: 28404944
    [Abstract] [Full Text] [Related]

  • 7. Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.
    Miki K, Al-Refaie W, Xu M, Jiang P, Tan Y, Bouvet M, Zhao M, Gupta A, Chishima T, Shimada H, Makuuchi M, Moossa AR, Hoffman RM.
    Cancer Res; 2000 May 15; 60(10):2696-702. PubMed ID: 10825143
    [Abstract] [Full Text] [Related]

  • 8. The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model.
    Higuchi T, Sugisawa N, Yamamoto J, Oshiro H, Han Q, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Tan Y, Kuchipudi S, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.
    Cancer Chemother Pharmacol; 2020 Feb 15; 85(2):285-291. PubMed ID: 31705268
    [Abstract] [Full Text] [Related]

  • 9. DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts.
    Morinaga S, Han Q, Kubota Y, Mizuta K, Kang BM, Sato M, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM.
    Anticancer Res; 2024 Jun 15; 44(6):2359-2367. PubMed ID: 38821601
    [Abstract] [Full Text] [Related]

  • 10. Afterword: Oral Methioninase-Answer to Cancer and Fountain of Youth?
    Hoffman RM, Han Q, Kawaguchi K, Li S, Tan Y.
    Methods Mol Biol; 2019 Jun 15; 1866():311-322. PubMed ID: 30725426
    [Abstract] [Full Text] [Related]

  • 11. High Efficacy of Recombinant Methioninase on Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Cancer.
    Hoffman RM, Murakami T, Kawaguchi K, Igarashi K, Tan Y, Li S, Han Q.
    Methods Mol Biol; 2019 Jun 15; 1866():149-161. PubMed ID: 30725414
    [Abstract] [Full Text] [Related]

  • 12. Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.
    Kawaguchi K, Han Q, Li S, Tan Y, Igarashi K, Kiyuna T, Miyake K, Miyake M, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Singh AS, Eckardt MA, Unno M, Eilber FC, Hoffman RM.
    Cell Cycle; 2018 Jun 15; 17(3):356-361. PubMed ID: 29187018
    [Abstract] [Full Text] [Related]

  • 13. [Recombinant methioninase regulates PI3K/Akt/Glut-1 pathway and inhibits aerobic glycolysis to promote apoptosis of gastric cancer cells].
    Zhou L, Li S, Liu L, Zhou Q, Yuan Y, Xin L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan 30; 40(1):27-33. PubMed ID: 32376548
    [Abstract] [Full Text] [Related]

  • 14. Recombinant Methioninase Increases Eribulin Efficacy 16-fold in Highly Eribulin-resistant HT1080 Fibrosarcoma Cells, Demonstrating Potential to Overcome the Clinical Challenge of Drug-resistant Soft-tissue Sarcoma.
    Morinaga S, Han Q, Mizuta K, Kang BM, Sato M, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM.
    Anticancer Res; 2024 Sep 30; 44(9):3777-3783. PubMed ID: 39197933
    [Abstract] [Full Text] [Related]

  • 15. Expression of PD-L1 Is Increased by Methionine Restriction Using Recombinant Methioninase in Human Colorectal Cancer Cells.
    Mizuta K, Kang BM, Han Q, Kubota Y, Morinaga S, Sato M, Bouvet M, Tome Y, Nishida K, Hoffman RM.
    Cancer Genomics Proteomics; 2024 Sep 30; 21(4):395-398. PubMed ID: 38944421
    [Abstract] [Full Text] [Related]

  • 16. Safety and Toxicity of Recombinant Methioninase and Polyethylene Glycol (PEG) Recombinant Methioninase in Primates.
    Hoffman RM, Yang Z, Tan Y, Han Q, Li S, Yagi S.
    Methods Mol Biol; 2019 Sep 30; 1866():211-229. PubMed ID: 30725418
    [Abstract] [Full Text] [Related]

  • 17. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.
    Sun X, Yang Z, Li S, Tan Y, Zhang N, Wang X, Yagi S, Yoshioka T, Takimoto A, Mitsushima K, Suginaka A, Frenkel EP, Hoffman RM.
    Cancer Res; 2003 Dec 01; 63(23):8377-83. PubMed ID: 14678999
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.